| Oct 15 |
Wall Street Analysts Predict a 41.4% Upside in Blueprint Medicines (BPMC): Here's What You Should Know
|
| Sep 27 |
Blueprint Medicines: Growth For The Long Term Still Mostly Priced In
|
| Sep 16 |
Strength Seen in Denali Therapeutics (DNLI): Can Its 10.1% Jump Turn into More Strength?
|
| Sep 16 |
High Growth Tech Stocks To Watch In September 2024
|
| Sep 10 |
Blueprint Medicines to Present at Upcoming Investor Conferences
|
| Sep 5 |
Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report?
|
| Aug 19 |
Insider Sale: CFO Michael Landsittel Sells Shares of Blueprint Medicines Corp (BPMC)
|
| Aug 9 |
Blueprint Medicines (BPMC) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
|
| Aug 7 |
Masimo (MASI) Q2 Earnings Beat Estimates, Gross Margin Up
|
| Aug 7 |
Analysts Just Shipped A Sizeable Upgrade To Their Blueprint Medicines Corporation (NASDAQ:BPMC) Estimates
|
